Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Endoscopic Olecranon Bursectomy in the Treatment of Recalcitrant Olecranon Bursitis: Patient Selection and Operative Technique.
Arthrosc Tech
January 2024
Division of Neuroscience and Spine Associates, Orthocollier, Naples, Florida, U.S.A.
Article Synopsis
- Olecranon bursitis is the most common type of bursitis and is usually treated with noninvasive methods; however, some cases require surgery when these treatments fail.
- Traditionally, recalcitrant cases have been addressed through open bursectomy, but there's a growing interest in using arthroscopy as a less invasive alternative.
- Although there isn’t a clear consensus on the best surgical method yet, the endoscopic approach could lead to better recovery outcomes, like less discomfort and a quicker return to normal activities.
No Wound Healing Complications or Recurrences Were Seen and a High Level of Satisfaction Was Reported in Patients Who Underwent Endoscopic Olecranon Bursectomy for Recalcitrant Olecranon Bursitis.
Arthrosc Sports Med Rehabil
February 2024
OrthoCollier, Naples, Florida, U.S.A.
Article Synopsis
- - The study aimed to evaluate the effectiveness and outcomes of endoscopic olecranon bursectomy for treating chronic olecranon bursitis, focusing on patient demographics, types of bursitis, and complications.
- - Data was collected from 28 patients who underwent the procedure between January 2018 and May 2021, revealing a mix of aseptic (54%) and septic (46%) bursitis cases, with a follow-up period averaging 24.7 months.
- - Results showed that 86% of patients reported no issues post-surgery, and there were no instances of recurrence or the need for additional operations; however, four patients experienced minor complications within three months of the procedure.
Miliarial-type gout in association with chronic use of glucocorticoids.
Rheumatol Int
March 2024
Rheumatology Division, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
Article Synopsis
- * Despite his serum uric acid levels being managed, he developed new intradermal tophi, described as "miliarial-type gout," leading to surgery for his olecranon bursa due to functional limitations.
- * The case highlights persistent tophi formation despite treatment, the potential relationship between glucocorticoid use and gout symptoms, and the coexistence of urate and cholesterol crystals in olecranon bursitis, along with a novel sonographic view of the condition
Rare Presentation of Disseminated Gout Nodulosis and Chronic Inflammatory Arthritis.
Case Rep Rheumatol
June 2023
John H. Stroger Jr. Hospital of Cook County, 1969 W Ogden Ave, Chicago, IL 60612, USA.
Background: Gout is an inflammatory arthritis caused by monosodium urate (MSU) deposition. Acute gout is a dramatic painful swelling of the joint; however, MSU can deposit in other tissues as well, including skin, gastrointestinal tract, and bones over time. Disseminated tophi in the skin are a rare presentation of gout known as gout nodulosis.
View Article and Find Full Text PDFOperative management of gouty tophi in the region of the olecranon: a case series.
JSES Int
May 2022
Division of Shoulder and Elbow, Department of Orthopedic Surgery, New York University Langone Health, New York, NY, USA.
Background: Tophaceous gout affecting the olecranon region can result in local discomfort, skin ulceration, secondary infection, and considerable disability if left untreated. However, there are limited reports of outcomes, including postoperative complications and recurrence after surgical excision of tophaceous gout deposits at the elbow. The aim of this study is to present our surgical technique and minimum one-year outcomes after surgical excision of tophaceous gout involving the elbow.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!